Charles E. Libby, RPh, MS

home / authors / charles-e-libby-rph-ms

Articles

Oncology Overview: Idelalisib in Blood Cancers

August 31st 2021

Approved indications for idelalisib include relapsed chronic lymphocytic leukemia, small lymphocytic lymphoma, and follicular B-cell non-Hodgkin lymphoma.

Do Not Sell My Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777